| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34dbaeed255e1c16f0b91d197febe78a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac767e9ab0855881abafebf8c4145f74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da63bfeba4eb70efd0a297fc5d24995b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2925c0fe8edaab3830d6e634e92f304f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-551 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| filingDate |
2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ae14a701fcbf18f77e8fc1e592978c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_785126d5d7584190a39e1f742f5b9a74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57c1d19b3078f26a7eab379e47fdce01 |
| publicationDate |
2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010126179-A1 |
| titleOfInvention |
Pharmaceutical composition comprising chlorine e6-folic acid conjugated compound and chitosan for treatment of cancer |
| abstract |
The present invention relates to a pharmaceutical composition comprising a chlorine e6-folic acid conjugated compound and chitosan for the treatment of cancer. More specifically, the present invention relates to a pharmaceutical composition comprising a chlorine e6-folic acid conjugated compound or a pharmaceutically acceptable salt thereof and chitosan as active ingredients for the photodynamic treatment of solid cancer, wherein the chlorine e6-folic acid conjugated compound is a new compound in the combined form of a chlorine e6 and a folic acid, produces singlet oxygen effectively in various media, and has a useful characteristic for the photodynamic therapy for a malignant tumor due to its remarkably excellent tumor selectivity compared with conventional porphyrin-based photosensitizers. |
| priorityDate |
2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |